MC

Mithlesh Chauhan

Active Director Designated Partner DIN 09248525
DIN 09248525 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Mithlesh Chauhan

Data last updated:

Mithlesh Chauhan is a Designated Partner at Ampure Pharmaceutical Llp (since 2021). The company operates in Pharma. Ampure Pharmaceutical Llp reported revenue of ₹1.3 Lakh (FY 2021).

DIN 09248525
Primary Designation Designated Partner
Industry Pharma
First Appointment 21 Jul 2021
Oldest Company Age 6 yrs
Largest company Ampure Pharmaceutical Llp · ₹1.3 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jul 20212020₹1.3 Lakh (FY 2021)Active

Board colleagues of Mithlesh Chauhan

NameDINCompanyDesignation
Arjun Singh Chauhan11407931Ampure Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ampure Pharmaceutical Llp
Premium access

Shareholding and investment profile for Mithlesh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithlesh Chauhan

Mithlesh Chauhan currently holds 1 directorship: Ampure Pharmaceutical Llp (Designated Partner, since 21 Jul 2021, revenue ₹1.3 Lakh (FY 2021)).

Mithlesh Chauhan was first appointed on 21 Jul 2021 as Designated Partner at Ampure Pharmaceutical Llp.

The current boards of Mithlesh Chauhan's companies include Arjun Singh Chauhan (Ampure Pharmaceutical Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available